Omitidox

Doxycycline 100 mg Injection | Omitidox


Brand Name – Omitidox

Composition – Doxycycline 100 mg Injection

Description

Doxycycline 100 mg Injection – Available at Sanify Healthcare by the brand name Omitidox, Doxycycline 100 mg Injection helps the user to treat and cure many types of bacterial infections. The severeness of the infections can range from mild, moderate, or severe. Doxycycline belongs to the group of tetracycline antibiotics that works by directly killing the infection-causing bacteria. By doing so, it stops the bacteria from spreading in the body and also improves its symptoms.

It is recommended by the healthcare experts to those patients who are suffering from bacterial infection, acne, UTI (Urinary Tract Infections), eye infections, periodontitis (gum disease), intestinal infections, gonorrhea, etc. Further Doxycycline can also be used to cure blemishes, acne-like lesions caused because of rosacea, bumps, etc.

The active properties of this medicine can lead to some side effects like injection site irritation, redness, itchiness, swelling, etc. Therefore, it is recommended to use this medicine under the supervision of a healthcare expert. Do not self administrator this injection. Also, make sure to do not skip any dosage in between and complete the full course of the medicines even if the symptoms disappear after some days. Stopping the cycle in between may worsen the condition and may allow the bacteria to grow again. Therefore, to reap out the best results, it is advised to use this injectable for the recommended period.

The user might encounter issues such as Nausea, Stomach upset, Diarrhea, Vaginal itching, Loss of appetite, etc. Although these issues do not require any medical attention as they will fade away as the body gets used to the drug. But in case the symptoms get worse, then it is highly recommended to consult your doctor.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Doxycycline 100 mg Injection | Omitidox”

Your email address will not be published.

Enquire Us
close slider